Rectal Neoplasms
Conditions
Brief summary
The aim of this retrospective national registry study is to validate the reporting of local recurrence in the registry. Another aim is to identify preoperative risk factors for local recurrence. This can in turn indicate the need for a more intense follow-up. The treatment of local recurrence, including the impact of the multidisciplinary team conference (MDT) and the surgical procedure and the referral pathways of local recurrences will also be determined. We aim to evaluate treatment outcome after local recurrence for patients operated or treated between 2007-2018.
Interventions
All types of treatment for local recurrence will be evaluated
Sponsors
Study design
Eligibility
Inclusion criteria
* Rectal cancer with a curative intent
Exclusion criteria
* Rectal cancer without curative intent
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Number of local recurrences | Between 2007-2018 |
| 3 year survival | 3 years |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Percentage R0 resection after local recurrence | 1-2 months after initiated treatment | — |
| MDT effect on treatment of local recurrence | 1-3 months after diagnosis of recurrence | — |
| Reported metastases | 5 years | Number of patients with metastasis reported vs actual |
| MRI features at primary diagnosis and relation to recurrence | 2 months | MRI evaluation by radiologist related to recurrence |
Countries
Sweden